Please Wait...

AAT-AD/PD Focus Meeting 2018, Torino, Italy

March 15, 2018 - 1:00am (EDT) to March 18, 2018 - 1:00am (EDT)

Join us at the Alzheimer’s disease/Parkinson’s disease conference in Torino where Bioclinica Research is pleased to be attending and speaking.

This exciting event is a new joint meeting between the International Geneva/Springfield Symposium on Advances in Alzheimer Therapy (AAT) and AD/PD. It is where to connect with others in the field and share about the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders. We invite you to participate in an informative session exploring ways to increase patient engagement and participation in Alzheimer’s disease clinical trials to be led by our own Marieke Cajal, Ph.D., Research Development Director, Bioclinica Research. Session details below.


Part of the "Care of AD Patients and Lifestyle” symposium beginning at 11 am in Sala Londra
Date and Time: March 18, 12:20 pm
Speaker: Marieke Cajal, Ph.D.

As part of this symposium, Dr. Cajal will discuss some of the greatest obstacles that stand in the way of patient engagement and participation in Alzheimer’s disease clinical trials and how to overcome them. She will provide real-life success stories drawn from her extensive work with this special patient population. As part of her talk, Dr. Cajal will share findings of the use of memory testing and APOE genetic testing in combination with patient and family counseling to increase engagement and participation in AD trials.

Event Website


Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil…
bioclinica (Yesterday)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace…
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c…
bioclinica (2 days ago)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '…
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen